Brent Hatzis-Schoch, Esq.

Brent Hatzis-Schoch, Esq.

Chief Operating Officer and General CounselatBlack Diamond Therapeutics· In proxies 2024–2025

Pay in FY2025-9% from the year before · Black Diamond Therapeutics stock +13.6% the same year

Brent Hatzis-Schoch, Esq. was paid $1.3M in FY2025 (Dec), down 9%. Black Diamond Therapeutics stock rose 13.6% that year.

Pay$100 in the stock at the end of FY23 → $86
Pay is from the Summary Compensation Table of each Black Diamond Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Black Diamond TherapeuticsPublic company · 2 yr
    • Chief Operating Officer and General Counsel2024 – Present · 2 yrStock in role -39%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?